West Pharmaceutical Services (WST) Short-term Investments (2011 - 2013)

West Pharmaceutical Services (WST) has reported Short-term Investments for 3 consecutive years, with $7.5 million the latest figure, recorded in Q4 2013.

• Quarterly Short-term Investments fell 39.52% year-over-year to $7.5 million in Q4 2013, while the trailing twelve-month figure through Dec 2013 was $7.5 million (down 39.52% YoY) and the FY2013 annual result came in at $7.5 million, down 39.52% from the prior year.
• Short-term Investments steadied at $7.5 million in Q4 2013 per WST's latest filing, from $7.5 million in the prior quarter.
• Over the last five years, Short-term Investments for WST reached as high as $26.5 million in Q4 2011 and fell as low as -$200000.0 in Q1 2012.
• A 3-year average of $12.6 million and a median of $8.9 million in 2011 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2012 — Short-term Investments plunged 102.08% — and 2013, when it soared 4200.0%.
• Year by year, Short-term Investments stood at $26.5 million in 2011, then sank by 53.21% to $12.4 million in 2012, then slumped by 39.52% to $7.5 million in 2013.
• According to Business Quant data, Short-term Investments over the past three periods registered $7.5 million, $7.5 million, and $7.5 million for Q4 2013, Q3 2013, and Q2 2013 respectively.